¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"È¿"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • ferment
    ¹ßÈ¿¼Ò
  • ferment fever
    ¹ßÈ¿¼Ò¿­
  • fermental diarrhea
    ¹ßÈ¿¼³»ç
  • fermentation
    ¹ßÈ¿
  • fermentation factor
    ¹ßÈ¿ÀÎÀÚ
  • fermentation fever
    ¹ßÈ¿¿­
  • fermentation test
    ¹ßÈ¿°Ë»ç
  • fermentative dyspepsia
    ¹ßÈ¿¼ÒÈ­ºÒ·®
  • fermentative organism
    ¹ßÈ¿±Õ
  • fermenter
    ¹ßÈ¿Åë
  • ferrochelatase
    ö°áÇÕÈ¿¼Ò
  • fibrinogenase
    ¼¶À¯¼ÒºÐÇØÈ¿¼Ò, ÇǺ긮³ë°ÕºÐÇØÈ¿¼Ò
  • fibrinolytic enzyme
    ¼¶À¯¼Ò¿ëÇØÈ¿¼Ò, ÇǺ기¿ëÇØÈ¿¼Ò
  • flavoenzyme
    Çöóº¸È¿¼Ò
  • fructokinase
    °ú´çÈ¿¼Ò, ÇÁ·èÅäŰ³ª¾ÆÁ¦
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • effective renal blood flow
    À¯È¿ÄáÆÏÇ÷·ù·®
  • effective renal plasma flow
    À¯È¿ÄáÆÏÇ÷Àå·ù·®
  • effective temperature index
    À¯È¿¿ÂµµÁö¼ö
  • electrophonic effect
    Àü±âû°¢È¿°ú
  • entry slice effect
    ÁøÀÔÀýÆíÈ¿°ú
  • extracellular enzyme
    ¼¼Æ÷¿ÜÈ¿¼Ò, ±Õü¹ÛÈ¿¼Ò
  • fast scan effect
    °í¼Ó½ºÄµÈ¿°ú
  • fibrinolytic enzyme
    ¼¶À¯¼Ò¿ëÇØÈ¿¼Ò
  • glycolytic enzyme
    ÇØ´çÈ¿¼Ò
  • gradient echo effect
    ±â¿ï±â¿¡ÄÚÈ¿°ú
  • halo effect
    ´Þ¹«¸®È¿°ú
  • healthy worker effect
    °Ç°­±Ù·ÎÀÚÈ¿°ú
  • in-flow effect
    À¯ÀÔÈ¿°ú
  • induced enzyme
    À¯µµÈ¿¼Ò
  • inhibitory effect
    ¾ïÁ¦È¿°ú
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • apoenzyme
    ¾ÆÆ÷È¿¼Ò
  • apoenzyme portion
    ¾ÆÆ÷È¿¼Ò ºÎºÐ
  • arginine decarboxylase reagent
    ¾Æ¸£±â´ÑŻī¸£º¹½ÇÈ¿¼Ò<--µ¥Ä«¸£º¹½Ç¶óÁ¦
  • arginosuccinic lyase
    ¾Æ¸£±â´ÑÈ£¹Ú»ê¸®¾ÆÁ¦<--Àý´ÜÈ¿¼Ò>
  • artificial age hardening
    Àΰø½ÃÈ¿°æÈ­(ìÑÍïãÁüùÌãûù).
  • free coagulase
    À¯¸®ÄھƱֶóÁ¦, À¯¸®Ç÷ÀåÀÀ°íÈ¿¼Ò
  • g6pd
    G6PD(Æ÷µµ´ç-6-Àλ꿰 Å»¼ö¼ÒÈ¿¼Ò)
  • g6pd deficiency
    G6PD(Æ÷µµ´ç-6-Àλ꿰 Å»¼ö¼ÒÈ¿¼Ò) °áÇÌÁõ
  • gactosyltransferase isoenzyme II
    °¥¶ôÅä½ÇÆ®¶õ½ºÆä¶óÁ¦µ¿Á¾<--µ¿È°>È¿¼Ò II
  • galactose-1-phosphate uridyl tranferase
    °¥¶ôÅ佺-1-Æ÷½ºÆäÀÌÆ®¿ì¸®µôÀüÀÌÈ¿¼Ò
  • gamma-glutamyl cysteine synthetase
    °¨¸¶-±Û·çŸ¹Ð½Ã½ºÅ×ÀÎÇÕ¼ºÈ¿¼Ò
  • gamma-glutamyl transferase
    °¨¸¶-±Û·çŸ¹ÐÀüÀÌÈ¿¼Ò
  • glucokinase
    ±Û·çÄÚÄ«À̳×À̽º, Æ÷µµ´çÈ¿¼Ò(øãÔ¬ÓØý£áÈ).
  • glucokinase
    ±Û·çÄÚŰ³ª¾ÆÁ¦, Æ÷µµ´çÈ¿¼Ò(øãÔ¬
  • glucose 6 phosphate dehydrogenase =G 6 PD
    ±Û·çÄÚ¿À½º 6Àλê Å»¼ö ¼ÒÈ¿¼Ò, ±Û·çÄÚ¿À½º-6-ÀÎ»ê µ¥È÷µå·Î°Ô³ªÁ¦.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • cost-efficiency analysis
    ºñ¿ë-È¿À²ºÐ¼®.
  • covalently modulated enzyme
    °øÀ¯°áÇÕ¸ðµâÈ­È¿¼Ò.
  • creatine kinase isoenzyme
    Å©·¹¾ÆÆ¾Å°³ªÁ¦À̼ҿ£ÀÚÀÓ<µ¿È°È¿¼Ò
  • crude efficiency
    Á¶È¿À²(̷̡Ëô).
  • cryptococcemia
    È¿¸ð±ÕÇ÷Áõ(ý£Ù½Ð¶úìñø)
  • cryptococcosis
    È¿¸ð±ÕÁõ.³»°úÅ©¸³ÅäÄÛ½ºº´.
  • cryptococcosis
    È¿¸ð±ÕÁõ(ý£Ù½Ð¶ñø)
  • cryptococcosis
    È¿¸ð±ÕÁõ.[³»°ú]Å©¸³ÅäÄÛ½ºº´.
  • cryptococcosis
    È¿¸ð±ÕÁõ
  • cumulative effect
    ´©ÀûÈ¿°ú, ÃàÀûÈ¿°ú.
  • cumulative radiation effect
    ´©Àû¹æ»ç¼±È¿°ú
  • cuprein enzyme
    Å¥ÇÁ·¹ÀÎÈ¿¼Ò
  • curative dose
    ġȿ·®(ö½üùåÖ).
  • curative effect
    Ä¡·áÈ¿°ú(ö½èþüùÍý).
  • curative effect
    Ä¡·áÈ¿°ú(Ä¡¿äÈ¿°ú).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • isodynamic enzyme
    ¾ÆÀ̼ҵ¿Àû(ÔÑîÜ) È¿¼Ò(ý£áÈ)
  • isoenzyme
    ¾ÆÀ̼ÒÈ¿¼Ò(ý£áÈ)
  • isofunctional enzymes
    µ¿±â´ÉÈ¿¼Ò(ÔÒÐüÒöý£áÈ)
  • isotope effect
    µ¿À§¿ø¼Ò È¿°ú(ÔÒêÈêªáÈüùÍý)
  • Johnston-Ogston effect
    ÁÔ½ºÅæ-¿À±×½ºÅæ È¿°ú(üùÍý)
  • joining enzyme
    Á¢ÇÕÈ¿¼Ò(ïÈùêý£áÈ)
  • kerr effect
    Äɸ£ È¿°ú(üùÍý)
  • key enzyme
    ¿­¼èÈ¿¼Ò(ý£áÈ)
  • kinetic isotope effect
    ¹ÝÀÀ¼Óµµ(ÚãëëáÜÓø) µ¿À§¿ø¼ÒÈ¿°ú(ÔÒêÈêªáÈüùÍý)
  • lactic acid fermentation
    ¶ôÆ®»ê(ß«)¹ßÈ¿(Û£ý£)
  • late enzyme
    ¸¸±âÈ¿¼Ò(عѢý£áÈ)
  • latent enzyme
    Àẹȿ¼Ò(íÖÜÑý£áÈ)
  • linear electric field effect
    ¼±Çü Àü±âÀåÈ¿°ú(àÊû¡ï³Ñ¨íÞüùÍý)
  • linked enzyme assay procedure
    ¿¬°èÈ¿¼Ò(ææÍ¨ý£áÈ) ¾Æ½êÀÌ ¹æ½Ä(Û°ãÒ)
  • lyoenzyme
    ¿ëÇØÈ¿¼Ò(éÁú°ý£áÈ)
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • matzoon
    ¹ßÈ¿À¯
    ¿ìÀ¯, ¾çÁ¥ µîÀÇ À½¿ëÀ¯³ª ±× Å»ÁöÀ¯¿¡ À¯»ê±ÕÀ» ÷°¡ÇÏ¿© Á¥ ¼Ó¿¡ µé¾î ÀÖ´Â Á¥´çÀ» À¯»ê ¹ßÈ¿½ÃŲ À¯Á¦Ç°. À¯»ê±Õ°ú È¿¸ð¸¦ º´¿ë½ÃŲ °Íµµ Àִµ¥ ÀÌ °æ¿ì¿¡´Â ¾à°£ÀÇ ¾ËÄÚ¿Ã ¹ßÈ¿¸¦ µ¿¹ÝÇÑ´Ù. Á¥Àº ¿µ¾çÀÌ Ç³ºÎÇÑ ½ÄǰÀ¸·Î À¯ÇØ ¼¼±Õ¿¡ ÀÇÇÑ ºÎÆÐ°¡ ÀϾ±â ½±´Ù. ÇÑÆí Á¥À» Â¥´Â ȯ°æ¿¡¼­´Â ¾ß»ýÀÇ À¯»ê±ÕÀ̳ª È¿¸ð°¡ ºÐÆ÷µÇ¾î ÀÖ¾î Á¥À» § ÈÄ¿¡ °¡¿­ »ì±ÕÀ» ÇÏÁö ¾Ê°í ±×´ë·Î ¹æÄ¡ÇØ µÎ¸é ½±°Ô À¯»ê ¹ßÈ¿°¡ ÀϾ À¯»êÀÌ »ý±ä´Ù. ±× °á°ú Á¥ ¼ÓÀÇ ´Ü¹éÁúÀÌ »ê¿¡ ÀÇÇØ µÎºÎ ¸ð¾çÀ¸·Î ÀÀ°íµÇ°í µ¿½Ã¿¡ ÀϹÝÀûÀ¸·Î »ê¿¡ ¾àÇÑ À¯ÇØ ¼¼±ÕÀÇ ¹ø½ÄÀÌ ¾ïÁ¦µÇ¾î º¸Á¸¼ºÀÌ ÁÁ¾ÆÁø´Ù. µû¶ó¼­ ¿¹·ÎºÎÅÍ ¸ñÃà»çȸ¿¡¼­´Â § Á¥À» ±×´ë·Î ¸¶½ÃÁö ¾Ê°í ¹ßÈ¿À¯ÀÇ ÇüÅ·Π¸¶¼Ì´Âµ¥, ¸ù°ñ, Àεµ, Áß±Ùµ¿ÀÇ ¿©·¯ ³ª¶ó¿Í ÅÍŰ, ¹ßÄ­ ¿©·¯ ³ª¶óÀÇ ¿ä±¸¸£Æ®, ±×¸®°í ºÏÀ¯·´ µî¿¡¼­µµ ±× ¿¹°¡ ³ªÅ¸³­´Ù. ¶Ç È¿¸ð¿¡ ÀÇÇØ¼­ ¾ËÄÚ¿Ã ¹ßÈ¿¸¦ µ¿¹ÝÇÑ °ÍÀ¸·Î Ä«ÇÁÄ«½ºÀÇ ÄÉÆÛ, ´ë·ú ³»ºÎÀÇ Äí¹Ì½º µîµµ ¸ðµÎ ¹ßÈ¿À¯ÀÇ ÀÏÁ¾ÀÌ´Ù.
  • mean effective dose
    50% À¯È¿·®
  • mesocatalyst
    Áß°£ È¿¼Ò
    ¿òÁ÷ÀÌÁö ¾Ê´Â Áß½ÉÀû È¿¼Ò¿Í ¿òÁ÷ÀÏ ¼ö ÀÖ´Â °ÍÀÇ Áß°£¿¡ ÀÖÀ¸¸é¼­ ÀÛ¿ëÇÏ´Â ´ãü.
  • metalloenzyme
    ±Ý¼Ó ÇÔÀ¯ È¿¼Ò
    ±¸Á¶ ³»¿¡ ±¸¼º ¿ä¼Ò·Î¼­ ±Ý¼Ó ¿øÀÚ¿Í °­ÇÏ°Ô °áÇÕÇÑ È¿¼Ò.
  • metalloproteinase
    ±Ý¼Ó ´Ü¹é ºÐÇØ È¿¼Ò
  • microsomal enzyme
    ¹Ì¼Òü È¿¼Ò
  • microsomal enzyme system
    ¹Ì¼Òü È¿¼Ò°è
  • minimum useful density
    ÃÖ¼Ò À¯È¿ ³óµµ
  • misregistration effect
    ¿Àµî·Ï È¿°ú
  • modulating effect
    Á¶Àý È¿°ú
  • monoamine oxidase
    ¸ð³ë ¾Æ¹Î »êÈ­ È¿¼Ò, ¸ð³ë¾Æ¹Î ¿Á½Ã´ÙÁ¦
  • muscle effect
    ±ÙÀ° È¿°ú
  • myosinferment
    ¸¶ÀÌ¿À½Å ¹ßÈ¿¼Ò
  • Nagler effect
    ³ª±Û·¯ È¿°ú
  • neural enzyme system
    ½Å°æ È¿¼Ò°è
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • effective exchange rate
    (±ÝÀ¶)½ÇÈ¿ ȯ½Ã¼¼(ȯÀ²)(±¹Á¦ÅëÈ­±â±ÝÀÌ ´çÇØ±¹°ú ´Ù¸¥ ÁÖ¿ä 20°³±¹ ÅëÈ­ÀÇ È¯½Ã¼¼¸¦ º¹ÇÕ½ÃÄÑ »êÃâÇÏ´Â Áö¼ö)
  • effective range
    (°ø)À¯È¿ »ç°Å¸®(»çÁ¤)
  • effectively
    À¯È¿ÇϰÔ;½ÇÁ¦»ó
  • effectiveness
    À¯È¿(¼º);È¿°úÀûÀÓ
  • effector
    È¿°ú±â(½Å°æ ÀÚ±ØÀ» ¹Ù´Ù ÀÛ¿ëÇÏ´Â ¸»ÃÊ Á¶Á÷)
  • effectual
    È¿°úÀûÀÎ;À¯È¿ÇÑ;À¯·ÂÇÑ
  • effectuate
    À¯È¿ÇϰÔÇÏ´Ù;ÀÌ·ç´Ù;´Þ¼ºÇÏ´Ù
  • efficacious
    À¯È¿ÇÑ
  • efficacy
    È¿·Â
  • efficiency
    ´É·ü;´É·Â;È¿·Â;È¿À²
  • efficient
    È¿°úÀÖ´Â;À¯´ÉÇÑ;´É·üÀûÀÎ
  • efficient market hypothesis
    (Áõ±Ç)È¿À²Àû ½ÃÀå °¡¼³(»õ·Î¿î Á¤º¸ÀÇ ÁÖ°¡¿¡ÀÇ ¹ÝÀÀÀº µ¿½ÃÀûÀ̶õ °¡¼³)
  • electrodelic
    Àü±¤¿¡ ÀÇÇØ ȯ°¢ÀûÀÎ È¿°ú¸¦ ³»´Â
  • electrofishing
    (¼ö»ê)Àü·ù ¾î¹ý(Á÷·ù Àü¿øÀÇ Áý¾î È¿°ú¸¦ ÀÌ¿ëÇÑ °Í)
  • electrooptic effect
    (Àü)Àü±â ±¤ÇÐ È¿°ú
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 11
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 11
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á